Literature DB >> 11895003

The nuclear pore complex is involved in nuclear transfer of plasmid DNA condensed with an oligolysine-RGD peptide containing nuclear localisation properties.

M Colin1, S Moritz, P Fontanges, M Kornprobst, C Delouis, M Keller, A D Miller, J Capeau, C Coutelle, M C Brahimi-Horn.   

Abstract

One of the major barriers to efficient gene transfer and expression of nonviral vectors for gene therapy is passage across the nuclear envelope. We have previously shown that an oligolysine-RGD peptide that condenses plasmid DNA and binds to cell surface integrins can mediate increased internalisation of plasmid DNA into cells and synergistic enhancement of gene expression when complexed to a cationic lipid. In this report, we show that this enhancement is due to increased nuclear transfer of the plasmid DNA. We have applied the digitonin-permeabilised cell system that has been well established for the study of the nuclear transport of proteins to examine the nuclear transfer of plasmid DNA. Nuclear transfer of plasmid DNA complexed to an oligolysine-RGD peptide and lipofectamine appears to be an energy-dependent process involving the nuclear pore complex, since it is inhibited at 4 degrees C and by treatment with wheat germ agglutinin or with an antibody to the nuclear pore complex which all block nuclear protein import. In accordance with active nuclear transport, we have shown that all these treatments inhibit expression of a luciferase reporter plasmid in permeabilised cells. Nuclear transfer of pDNA is enhanced in mitotic cells, but cell division is not a prerequisite for transfer. We propose that the oligolysine-RGD peptide acts as a nuclear localisation signal and that the cationic lipid is more important for cell entry and endosome destabilisation than nuclear transfer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11895003     DOI: 10.1038/sj.gt.3301572

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  9 in total

Review 1.  Intracellular trafficking of nucleic acids.

Authors:  Rui Zhou; R Christopher Geiger; David A Dean
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

Review 2.  Nuclear entry of nonviral vectors.

Authors:  D A Dean; D D Strong; W E Zimmer
Journal:  Gene Ther       Date:  2005-06       Impact factor: 5.250

Review 3.  The nuclear pore complex: the gateway to successful nonviral gene delivery.

Authors:  Marieke A E M van der Aa; Enrico Mastrobattista; Ronald S Oosting; Wim E Hennink; Gerben A Koning; Daan J A Crommelin
Journal:  Pharm Res       Date:  2006-03-15       Impact factor: 4.200

4.  Screening a chemically defined extracellular matrix mimetic substrate library to identify substrates that enhance substrate-mediated transfection.

Authors:  Andrew Hamann; Alvin K Thomas; Tyler Kozisek; Eric Farris; Steffen Lück; Yixin Zhang; Angela K Pannier
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-17

5.  Cell-specific nuclear import of plasmid DNA in smooth muscle requires tissue-specific transcription factors and DNA sequences.

Authors:  A M Miller; D A Dean
Journal:  Gene Ther       Date:  2008-05-22       Impact factor: 5.250

6.  The SP-C promoter facilitates alveolar type II epithelial cell-specific plasmid nuclear import and gene expression.

Authors:  J V Degiulio; C D Kaufman; D A Dean
Journal:  Gene Ther       Date:  2010-01-07       Impact factor: 5.250

Review 7.  Solid-phase supported design of carriers for therapeutic nucleic acid delivery.

Authors:  Ana Krhac Levacic; Stephan Morys; Ernst Wagner
Journal:  Biosci Rep       Date:  2017-10-31       Impact factor: 3.840

Review 8.  Membrane Trafficking and Subcellular Drug Targeting Pathways.

Authors:  Ajay Kumar; Anas Ahmad; Akshay Vyawahare; Rehan Khan
Journal:  Front Pharmacol       Date:  2020-05-27       Impact factor: 5.810

Review 9.  Tailoring Iron Oxide Nanoparticles for Efficient Cellular Internalization and Endosomal Escape.

Authors:  Laura Rueda-Gensini; Javier Cifuentes; Maria Claudia Castellanos; Paola Ruiz Puentes; Julian A Serna; Carolina Muñoz-Camargo; Juan C Cruz
Journal:  Nanomaterials (Basel)       Date:  2020-09-11       Impact factor: 5.076

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.